Role of Interleukin 6 (Il-6) and Tumor Necrosis Factor (TNF) in Burn Eschar Bacterial Colonization and Wound Healing

2006 ◽  
Vol 27 (Supplement) ◽  
pp. S111
Author(s):  
V Hamrahi ◽  
M Hamblin ◽  
E A. Carter ◽  
J Benjamin ◽  
K P. Francis ◽  
...  
2004 ◽  
Vol 279 (18) ◽  
pp. 18648-18655 ◽  
Author(s):  
Sophie Malagarie-Cazenave ◽  
Bruno Ségui ◽  
Sophie Lévêque ◽  
Virginie Garcia ◽  
Stéphane Carpentier ◽  
...  

2017 ◽  
Vol 21 (1) ◽  
pp. 14-19 ◽  
Author(s):  
Masae Ritsu ◽  
Kazuyoshi Kawakami ◽  
Emi Kanno ◽  
Hiromasa Tanno ◽  
Keiko Ishii ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Roozbeh Khosravi ◽  
Khady Ka ◽  
Ting Huang ◽  
Saeed Khalili ◽  
Bich Hong Nguyen ◽  
...  

Obesity has become a worldwide health burden in the last two decades. Obesity has been associated with increased comorbidities, such as coronary artery disease, diabetes, and destructive periodontal disease. Obesity is also part of a group of risk factors occurring together in an individual, which is referred to as metabolic syndrome. Clinical studies have shown higher risk for destructive periodontal disease in obesity and metabolic syndrome. However, the role of obesity and metabolic syndrome in the onset and development of destructive periodontal disease has not yet been fully understood. In this review, we discuss a working model, which focuses on interorgan inflammation as a common etiological factor for destructive periodontal disease associated with obesity and metabolic syndrome. Specifically, we suggest that elevated levels of tumor necrosis factor-α(TNF-α) or interleukin 6 (IL-6)—both adipokines and known risk factors for destructive periodontal disease—in obesity and metabolic syndrome contribute to the onset and development of destructive periodontal disease. The connections between destructive periodontal disease and systemic conditions, such as obesity or metabolic syndrome, are complex and potentially multidirectional. This review largely focuses on TNF-αand IL-6, inflammatory mediators, as potential common risk factors and does not exclude other biological mechanisms.


2016 ◽  
Vol 2016 ◽  
pp. 1-13 ◽  
Author(s):  
Xinjing Luo ◽  
Jie Chen ◽  
Jianwei Ruan ◽  
Yongfeng Chen ◽  
Xuanrong Mo ◽  
...  

Human fibroblast-like synoviocytes play a vital role in joint synovial inflammation in rheumatoid arthritis (RA). Proinflammatory cytokines induce fibroblast-like synoviocyte activation and dysfunction. The inflammatory mediator Krüppel-like factor 4 is upregulated during inflammation and plays an important role in endothelial and macrophage activation during inflammation. However, the role of Krüppel-like factor 4 in fibroblast-like synoviocyte activation and RA inflammation remains to be defined. In this study, we identify the notion that Krüppel-like factor 4 is higher expressed in synovial tissues and fibroblast-like synoviocytes from RA patients than those from osteoarthritis patients.In vitro, the expression of Krüppel-like factor 4 in RA fibroblast-like synoviocytes is induced by proinflammatory cytokine tumor necrosis factor-α. Overexpression of Krüppel-like factor 4 in RA fibroblast-like synoviocytes robustly induced interleukin-6 production in the presence or absence of tumor necrosis factor-α. Conversely, knockdown of Krüppel-like factor 4 markedly attenuated interleukin-6 production in the presence or absence of tumor necrosis factor-α. Krüppel-like factor 4 not only can bind to and activate the interleukin-6 promoter, but also may interact directly with nuclear factor-kappa B. These results suggest that Krüppel-like factor 4 may act as a transcription factor mediating the activation of fibroblast-like synoviocytes in RA by inducing interleukin-6 expression in response to tumor necrosis factor-α.


Sign in / Sign up

Export Citation Format

Share Document